ABUS
Price
$4.22
Change
+$0.04 (+0.96%)
Updated
Oct 9 closing price
Capitalization
962.79M
31 days until earnings call
Intraday BUY SELL Signals
IDNA
Price
$42.17
Change
+$1.75 (+4.33%)
Updated
Oct 9 closing price
Net Assets
307.68M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABUS vs IDNA

ABUS vs IDNA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABUS vs. IDNA commentary
Oct 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABUS is a Hold and IDNA is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ABUS: Fundamental Ratings
ABUS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
15
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
25
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABUSIDNA
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
87%
COMPARISON
Comparison
Oct 11, 2026
Stock price -- (ABUS: $4.22)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABUS’s FA Score shows that 2 FA rating(s) are green while .

  • ABUS’s FA Score: 2 green, 3 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABUS’s TA Score shows that 3 TA indicator(s) are bullish.

  • ABUS’s TA Score: 3 bullish, 6 bearish.

Price Growth

ABUS (@Biotechnology) experienced а -5.17% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.51%. For the same industry, the average monthly price growth was -13.43%, and the average quarterly price growth was -4.26%.

Reported Earning Dates

ABUS is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-2.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABUS
Daily Signal:
Gain/Loss:
IDNA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FFC14.780.16
+1.09%
Flaherty & Crumrine Preferred and Income Securities Fund
ESGU170.521.13
+0.67%
iShares ESG Aware MSCI USA ETF (ESGU)
CEFA39.950.26
+0.67%
Global X S&P Catholic Values Developed ex-US ETF (CEFA)
RIOX15.840.05
+0.32%
Tidal Trust II Defiance Daily Target 2X Long RIOT ETF
HTAB17.970.05
+0.28%
Hartford Schroders Tax-Aware Bond ETF (HTAB)

ABUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with ARRY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABUS
1D Price
Change %
ABUS100%
+0.96%
ARRY - ABUS
43%
Loosely correlated
-1.87%
AXON - ABUS
42%
Loosely correlated
+1.34%
KURA - ABUS
42%
Loosely correlated
+0.76%
RCKT - ABUS
42%
Loosely correlated
-2.66%
MGTX - ABUS
42%
Loosely correlated
+1.81%
More

IDNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDNA has been loosely correlated with FATE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IDNA jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDNA
1D Price
Change %
IDNA100%
+4.33%
FATE - IDNA
57%
Loosely correlated
+2.35%
SANA - IDNA
51%
Loosely correlated
N/A
BNGO - IDNA
51%
Loosely correlated
-1.71%
ABUS - IDNA
51%
Loosely correlated
+0.96%
MRK - IDNA
50%
Loosely correlated
+2.26%
More